A detailed history of Smith Anglin Financial, LLC transactions in Danaher Corp stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 772 shares of DHR stock, worth $181,458. This represents 0.02% of its overall portfolio holdings.

Number of Shares
772
Previous 905 14.7%
Holding current value
$181,458
Previous $226,000 5.31%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$239.25 - $280.76 $31,820 - $37,341
-133 Reduced 14.7%
772 $214,000
Q2 2024

Jul 10, 2024

SELL
$235.51 - $267.98 $5,652 - $6,431
-24 Reduced 2.58%
905 $226,000
Q1 2024

Apr 24, 2024

SELL
$224.58 - $256.19 $3,144 - $3,586
-14 Reduced 1.48%
929 $231,000
Q4 2023

Jan 17, 2024

BUY
$185.1 - $233.13 $370 - $466
2 Added 0.21%
943 $218,000
Q3 2023

Oct 11, 2023

SELL
$233.08 - $265.59 $3,263 - $3,718
-14 Reduced 1.47%
941 $233,000
Q2 2023

Jul 10, 2023

SELL
$224.99 - $256.14 $4,049 - $4,610
-18 Reduced 1.85%
955 $229,000
Q1 2023

Apr 11, 2023

BUY
$239.75 - $277.0 $9,350 - $10,803
39 Added 4.18%
973 $245,000
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $5,069 - $5,928
21 Added 2.3%
934 $247,000
Q3 2022

Oct 24, 2022

BUY
$247.06 - $1507.4 $247 - $1,507
1 Added 0.11%
913 $236,000
Q2 2022

Jul 25, 2022

SELL
$237.11 - $299.66 $1,422 - $1,797
-6 Reduced 0.65%
912 $231,000
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $2,058 - $2,526
8 Added 0.88%
918 $269,000
Q4 2021

Jan 31, 2022

BUY
$292.08 - $329.01 $38,262 - $43,100
131 Added 16.82%
910 $300,000
Q3 2021

Oct 20, 2021

BUY
$272.21 - $332.43 $272 - $332
1 Added 0.13%
779 $237,000
Q2 2021

Aug 10, 2021

BUY
$225.08 - $271.69 $175,112 - $211,374
778 New
778 $209,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Smith Anglin Financial, LLC Portfolio

Follow Smith Anglin Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Anglin Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Anglin Financial, LLC with notifications on news.